INFECTION CAUSED BY ESCHERICHIA COLI O157:H7 – CASE REPORT

  • Janja Blatnik Oddelek za infekcijske bolezni in vročinska stanja Splošna bolnišnica Celje Oblakova 5 3000 Celje
  • Gorazd Lešničar Oddelek za infekcijske bolezni in vročinska stanja Splošna bolnišnica Celje Oblakova 5 3000 Celje
  • Branko Šibanc Oddelek za infekcijske bolezni in vročinska stanja Splošna bolnišnica Celje Oblakova 5 3000 Celje
  • Stella Cvitan Oddelek za infekcijske bolezni in vročinska stanja Splošna bolnišnica Celje Oblakova 5 3000 Celje
Keywords: hemorrhagic enterocolitis, verotoxin ll, bicytopenia, microhematuria, proteinuria

Abstract

Background. Escherichia coli O157:H7 causes hemorrhagic colitis and is associated with serious complications, which include hemolytic uremic syndrome, thrombocytopenic purpura, and death.

Patient and methods. A 3-years old girl with infection by Escherichia coli O157:H7 presented with hemorrhagic colitis, bicytopenia and proteinuria with microhematuria. Diarrhoea subsided in a few days without specific therapy, complications subsided during treatment with aminoglycoside antibiotic.

Conclusions. Infection by Escherichia coli O157:H7 must be recognised in time especialy in young children and in the olderly. In these groups this infection often leads to serious complications, even death.

Downloads

Download data is not yet available.

References

Čižman M, Glušič M, Andlovic A. Diarealni sindrom pri otrocih. In: Zbornik strokovnega srečanja Okužbe in zastrupitve prebavil, Gozd Martuljek. Ljubljana: Sekcija za klinično mikrobiologijo in hospitalne infekcije, 1997: 29–35.

Wanke CA. Enteropathogenic and enteroaggregative strains of Escherichia coli: Clinical features of infection, epidemiology, and pathogenesis. Curr Clin Top Infect Dis 1997; 70: 230–48.

Čižman M, Furman M, Lužnik-Bufon T, Janc M, Poljšak-Prijatelj M, Mozetič M. Vloga nekaterih »novih« enteropatogenih agensov v etiologiji akutne diareje pri otrocih. Zdrav Vestn 1989; 58: 53–6.

Parsonnet J, Griffin PM. Hemolytic uremic syndrome: clinical picture and bacterial connection. Curr Clin Top Infect Dis 1994; 30: 172–87.

Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995; 10: 364–7.

Andlovic A. Novi problemi z E. coli. In: Zbornik strokovnega srečanja Okužbe in zastrupitve prebavil, Gozd Martuljek. Ljubljana: Sekcija za klinično mikrobiologijo in hospitalne infekcije, 1997: 52–4.

Roe AJ, Gally DL. Enteropathogenic and enterohaemorrhagic Escherichia coli and diarrhoea. Curr Opin Infect Dis 2000; 13: 511–7.

Breznik B. Verotoksična (enterohemoragična) Escherichia coli. In: Zbornik strokovnega srečanja Okužbe in zastrupitve prebavil, Gozd Martuljek. Ljubljana: Sekcija za klinično mikrobiologijo in hospitalne infekcije, 1997: 55–8.

Dundas S, Todd A. Escherichia coli O157 and human disease. Curr Opin Infect Dis 1998; 11: 171–5.

Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolyticuremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342: 1930–6.

Zhang X, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DWK. Quinolone antibiotics induce shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis 2000; 181: 664–70.

Kraigher A, Hočevar-Grom A, Klavs I et al. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 1997. Zdrav Var 1998; 37: 65–5.

Kraigher A, Hočevar-Grom A, Klavs I et al. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 1998. Zdrav Var 1999; 38: 63–3.

Kraigher A, Hočevar-Grom A, Klavs I et al. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 1999. Zdrav Var 2000; 39: 65–5.

Kraigher A, Hočevar-Grom A, Klavs I et al. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 2000. Zdrav Var 2001; 40: 68–8.

Farthing MJG. Acute infectious diarrhea. In: Jeffers JD, Bruno F. Gastroenterology and hepatology. London: McGraw Hill, 1999: 83–93.

Schmidt H, Karch H. Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol 1996; 2364–7.

Slustker L, Ries A, Greene KD, Wells JG, Hutwagner L, Griffin PM. Escherichia coli O157:H7 diarrhea in the United States: Clinical and epidemiologic features. Ann Itern Med 1997; 126: 505–13.

Stantič-Pavlinič M, Ščuka R, Dovečar D, Oražem T, Logar J. Črevesne okužbe na območju Ljubljane. Zdrav Vestn 2000; 69: 593–7.

Eisenstein BI. Enterobacteriace. In: Mandell GL, Bennett JE, Dolin R eds. Principles and practice of infectious diseases. 4th ed. Vol. 2. New York: Churchill Livingstone, 1995: 1964–71.

Guerrant RL, Van Gilder T, Steiner TS et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001; 32: 331–50.

Fornasini M, Reves RR, Murray BE, Morrow AL, Pickering LK. Trimethoprim – resistant Escherichia coli in households of children attending day care centers. J Infect Dis 1992; 166: 326–30.

How to Cite
1.
Blatnik J, Lešničar G, Šibanc B, Cvitan S. INFECTION CAUSED BY ESCHERICHIA COLI O157:H7 – CASE REPORT. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];71(7/8). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/1609
Issue
Vol 71 No 7/8 (2002): July/August
Section
Professional Article


The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.

The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory

The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.

The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.

The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.